Data Exploration for Target Predictions Using Proprietary and Publicly Available Data Sets

When applying machine learning (ML) approaches for the prediction of bioactivity, it is common to collect data from different assays or sources and combine them into single data sets. However, depending on the data domains and sources from which these data are retrieved, bioactivity data for the same macromolecular target may show a high variance of values (looking at a single compound) and cover very different parts of the chemical space as well as the bioactivity range (looking at the whole data set). The effectiveness and applicability domain of the resulting prediction models may be strongly influenced by the sources from which their training data were retrieved. Therefore, we investigated the chemical space and active/inactive distribution of proprietary pharmaceutical data from Bayer AG and the publicly available ChEMBL database, and their impact when applied as training data for classification models. For this end, we applied two different sets of descriptors in combination with different ML algorithms. The results show substantial differences in chemical space between the two different data sources, leading to suboptimal prediction performance when models are applied to domains other than their training data. MCC values between -0.34 and 0.37 among all targets were retrieved, indicating suboptimal model performance when models trained on Bayer AG data were tested on ChEMBL data and vice versa. The mean Tanimoto similarity of the nearest neighbors between these two data sources indicated similarities for 31 targets equal to or less than 0.3. Interestingly, all applied methods to assess overlap of chemical space of the two data sources to predict the applicability of models beyond their training data sets did not correlate with observed performances. Finally, we applied different strategies for creating mixed training data sets based on both public and proprietary sources, using assay format (cell-based and cell-free) information and Tanimoto similarities.

Authors

Institutions

Publication Details

Journal
Chemical Research in Toxicology
Published
2025-04-20
DOI
https://doi.org/10.1021/acs.chemrestox.4c00347
Citations
4
Primary Topic
Computational Drug Discovery Methods
Type
article
Field-Weighted Citation Impact
6.02

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Data Exploration for Target Predictions Using Proprietary and Publicly Available Data Sets

Gerhard Franz Ecker, Aljŏs̆a Smajíć, Thomas Steger‐Hartmann, Anke Hackl
4 citations
Chemical Research in Toxicology
Computational Drug Discovery Methods
6.02
article

Data Exploration for Target Predictions Using Proprietary and Publicly Available Data Sets

Gerhard Franz Ecker, Aljŏs̆a Smajíć, Thomas Steger‐Hartmann, Anke Hackl
article en
4 citations

Abstract

When applying machine learning (ML) approaches for the prediction of bioactivity, it is common to collect data from different assays or sources and combine them into single data sets. However, depending on the data domains and sources from which these data are retrieved, bioactivity data for the same macromolecular target may show a high variance of values (looking at a single compound) and cover very different parts of the chemical space as well as the bioactivity range (looking at the whole data set). The effectiveness and applicability domain of the resulting prediction models may be strongly influenced by the sources from which their training data were retrieved. Therefore, we investigated the chemical space and active/inactive distribution of proprietary pharmaceutical data from Bayer AG and the publicly available ChEMBL database, and their impact when applied as training data for classification models. For this end, we applied two different sets of descriptors in combination with different ML algorithms. The results show substantial differences in chemical space between the two different data sources, leading to suboptimal prediction performance when models are applied to domains other than their training data. MCC values between -0.34 and 0.37 among all targets were retrieved, indicating suboptimal model performance when models trained on Bayer AG data were tested on ChEMBL data and vice versa. The mean Tanimoto similarity of the nearest neighbors between these two data sources indicated similarities for 31 targets equal to or less than 0.3. Interestingly, all applied methods to assess overlap of chemical space of the two data sources to predict the applicability of models beyond their training data sets did not correlate with observed performances. Finally, we applied different strategies for creating mixed training data sets based on both public and proprietary sources, using assay format (cell-based and cell-free) information and Tanimoto similarities.

Chemical Research in ToxicologyVol. 38(5)
University of Vienna (AT), Bayer (Germany) (DE)
Austrian Science Fund
Openalex Percentile: Top 4%
Computational Drug Discovery Methods
6.02
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.